AEG vs AFG

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a seemingly attractive valuation with a P/E of 8.47 well below sector average and a current price below the Graham Number of $11.87, earnings volatility is extreme—recent YoY EPS growth is -3075% and Q/Q EPS growth is -1170%, signaling severe deterioration. Dividend strength is solid at 70/100 with a 5.76% yield and sustainable 44.48% payout ratio, but insider sentiment is weak at 40/100 and technical trend is deeply bearish at 10/100. Combined with erratic earnings surprises averaging -745.99% over the last four quarters, the stock appears fundamentally deteriorating despite surface-level value appeal.

AFG's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below its growth-based intrinsic value of $279.66 but above the conservative Graham Number of $109.99, suggesting moderate undervaluation with structural risks. Profitability metrics like ROE (16.91%) and low Debt/Equity (0.43) are strong, but weak revenue growth (-0.80% YoY) and bearish insider activity weigh on momentum. Analysts recommend a 'buy' with a target price of $143.83, implying 12.5% upside, though recent price performance has been flat to negative in the short term.